DOT-compliant and non-DOT drug testing across urine, hair follicle, oral fluid, and breath alcohol. Pre-employment, random, post-accident, and return-to-duty. Walk-in, mobile, and onsite collection nationwide.
Choose the testing method that fits your industry, your timeline, and your compliance requirements.
The most widely accepted testing method. DOT-compliant, SAMHSA-certified lab analysis, detects recent use across the standard 5-panel and expanded panels.
Detects drug use over a 90-day window. Ideal for pre-employment screening when you want a longer detection period than urine provides.
Quick, non-invasive, and observed collection. Useful for reasonable-suspicion and post-accident scenarios where same-day results matter.
DOT-certified evidential breath testing devices. Required for safety-sensitive positions under FMCSA, FAA, FRA, FTA, and PHMSA rules.
Call, email, or use our form. We'll quote based on test type, volume, and turnaround.
Walk-in to our La Grande office, schedule mobile collection at your site, or send your team to a partner clinic.
DOT-certified collectors maintain chain of custody from sample to lab. SAMHSA-certified lab analysis. Standing up your own collection site? See our DOT collector qualification training.
Medical Review Officer verifies positives. Results delivered securely in 48 to 72 hours, often faster.
Negative results are typically delivered securely in 48 to 72 hours, and often faster. Anything non-negative goes to a Medical Review Officer, who contacts the donor to check for a legitimate medical explanation before reporting a verified result — that review adds time, and it is a required step, not a delay.
The DOT panel is set by 49 CFR § 40.85, which fixes the cutoff concentrations every certified laboratory must use. It covers five classes: marijuana metabolites, cocaine metabolite, opioids (including codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone and 6-acetylmorphine), amphetamines, and PCP. Employers cannot add or remove analytes from a DOT test — non-DOT panels are where expanded testing belongs.
49 CFR § 40.67(b) is explicit: an employer must direct a collection under direct observation if the drug test is a return-to-duty test or a follow-up test. This is not discretionary and it is not something the donor can decline. Direct observation is also required in specific situations such as an invalid result with no adequate medical explanation.
Urine is the most widely accepted method and the only one currently usable for DOT testing. Hair detects use across roughly a 90-day window, which makes it useful for non-DOT pre-employment screening when you want a longer look-back than urine provides. Many employers run a DOT urine test for compliance and a hair test alongside it for their own hiring standard.
Three ways: walk in to our La Grande office, have us bring a mobile collector to your site, or send your team to a partner clinic. Partner clinic coverage is nationwide, so a driver on the road does not have to come back to Oregon to test.
Usually, yes — walk-in service is available at the La Grande office and we can mobilize for post-accident and reasonable-suspicion situations. Call (888) 869-0898. Note that before a supervisor can order a reasonable-suspicion test, they must have completed reasonable suspicion training — 49 CFR § 382.603 requires it, and § 382.307(c) requires the observation be made by a trained supervisor.
Whether you're enrolling one driver or building a program for 500 employees, we'll have you covered in one phone call.